Anti-proliferative therapy for HIV cure: a compound interest approach

Abstract In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integra...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Daniel B. Reeves, Elizabeth R. Duke, Sean M. Hughes, Martin Prlic, Florian Hladik, Joshua T. Schiffer
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/3bd56a0f58ac4f5799ab988ad7daaffa
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!